| 产品名称： | Cy34.1.2 |
|---|---|
| 商品货号： | TS212317 |
| Organism： | Mus musculus (B cell); Mus musculus (myeloma), mouse (B cell); mouse (myeloma) |
| Cell Type： | hybridoma: B lymphocyte |
| Product Format： | frozen |
| Morphology： | lymphoblast |
| Culture Properties： | suspension |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Storage Conditions： | liquid nitrogen vapor phase |
| Derivation： | Animals were immunized with spleen cells from B10.D2 mice. Spleen cells were fused with Sp2/0-Ag14 myeloma cells. |
| Genes Expressed： | immunoglobulin; monoclonal antibody; against Lyb 8.2 (mouse B cell antigen) |
| Cellular Products： | immunoglobulin; monoclonal antibody; against Lyb 8.2 (mouse B cell antigen) |
| Comments： | The antibody defines an antigen on mouse B cells that is expressed on pre B cells and mature B cells. The antibody is NOT cytotoxic and precipitates molecules with apparent molecular weights between 95000 and 105000 daltons. The Lyb 8.2 antigen expression is controlled by a locus on chromosome 7 that is closely linked to the Gpi-1 and RP-2 loci. Tested and found negative for ectromelia virus (mousepox). |
| Complete Growth Medium： | The base medium for this cell line is ATCC-formulated Dulbeccos Modified Eagles Medium, Catalog No. 30-2002. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
|
| Subculturing： | Cultures can be maintained by the addition of fresh medium or replacement of medium. Alternatively cultures can be established by centrifugation with subsequent resuspension at 1 x 105xa0viable cells/mL. Maintain culture density between 1 x 105xa0and 1 x 106xa0viable cells/mL.
Medium Renewal: Every 2 to 3 days |
| Cryopreservation： | Complete culture medium described above supplemented with 5% (v/v) DMSO. Cell culture tested DMSO is available as ATCC Catalog No. 4-X. |
| Culture Conditions： | Temperature: 37°Cxa0 |
| Isotype： | IgG1 |
| Name of Depositor： | FW Symington |
| Deposited As： | mouse (B cell); mouse (myeloma) |
| References： | Sprent J, et al. Lyb-8.2: a new B cell antigen defined and characterized with a monoclonal antibody. Immunogenetics 16: 381-391, 1982. PubMed: 6984010 Hay, R. J., Caputo, J. L., and Macy, M. L., Eds. (1992), ATCC Quality Control Methods for Cell Lines. 2nd edition, Published by ATCC. Caputo, J. L., Biosafety procedures in cell culture. J. Tissue Culture Methods 11:223-227, 1988. Fleming, D.O., Richardson, J. H., Tulis, J.J. and Vesley, D., (1995) Laboratory Safety: Principles and Practice. Second edition, ASM press, Washington, DC. Biosafety in Microbiological and Biomedical Laboratories, 5th ed. HHS. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. Washington DC: U.S. Government Printing Office; 2007. The entire text is available online. |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | Cy34.1.2 |
|---|---|
| 商品货号： | TS212317 |
| Organism： | Mus musculus (B cell); Mus musculus (myeloma), mouse (B cell); mouse (myeloma) |
| Cell Type： | hybridoma: B lymphocyte |
| Product Format： | frozen |
| Morphology： | lymphoblast |
| Culture Properties： | suspension |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Storage Conditions： | liquid nitrogen vapor phase |
| Derivation： | Animals were immunized with spleen cells from B10.D2 mice. Spleen cells were fused with Sp2/0-Ag14 myeloma cells. |
| Genes Expressed： | immunoglobulin; monoclonal antibody; against Lyb 8.2 (mouse B cell antigen) |
| Cellular Products： | immunoglobulin; monoclonal antibody; against Lyb 8.2 (mouse B cell antigen) |
| Comments： | The antibody defines an antigen on mouse B cells that is expressed on pre B cells and mature B cells. The antibody is NOT cytotoxic and precipitates molecules with apparent molecular weights between 95000 and 105000 daltons. The Lyb 8.2 antigen expression is controlled by a locus on chromosome 7 that is closely linked to the Gpi-1 and RP-2 loci. Tested and found negative for ectromelia virus (mousepox). |
| Complete Growth Medium： | The base medium for this cell line is ATCC-formulated Dulbeccos Modified Eagles Medium, Catalog No. 30-2002. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
|
| Subculturing： | Cultures can be maintained by the addition of fresh medium or replacement of medium. Alternatively cultures can be established by centrifugation with subsequent resuspension at 1 x 105xa0viable cells/mL. Maintain culture density between 1 x 105xa0and 1 x 106xa0viable cells/mL.
Medium Renewal: Every 2 to 3 days |
| Cryopreservation： | Complete culture medium described above supplemented with 5% (v/v) DMSO. Cell culture tested DMSO is available as ATCC Catalog No. 4-X. |
| Culture Conditions： | Temperature: 37°Cxa0 |
| Isotype： | IgG1 |
| Name of Depositor： | FW Symington |
| Deposited As： | mouse (B cell); mouse (myeloma) |
| References： | Sprent J, et al. Lyb-8.2: a new B cell antigen defined and characterized with a monoclonal antibody. Immunogenetics 16: 381-391, 1982. PubMed: 6984010 Hay, R. J., Caputo, J. L., and Macy, M. L., Eds. (1992), ATCC Quality Control Methods for Cell Lines. 2nd edition, Published by ATCC. Caputo, J. L., Biosafety procedures in cell culture. J. Tissue Culture Methods 11:223-227, 1988. Fleming, D.O., Richardson, J. H., Tulis, J.J. and Vesley, D., (1995) Laboratory Safety: Principles and Practice. Second edition, ASM press, Washington, DC. Biosafety in Microbiological and Biomedical Laboratories, 5th ed. HHS. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. Washington DC: U.S. Government Printing Office; 2007. The entire text is available online. |
